Chinese herbal medicine may improve outcomes after STEMI

CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and

Chinese herbal remedy 'just as effective as methotrexate against arthritis

Diabetes and Dietary Supplements: What You Need To Know

The traditional Chinese medicine that could become 'key treatment' for heart attacks, as study finds it lowers inflammation without adverse effects

PDF) Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model

Adaptogens: Types and Health Benefits

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials - eBioMedicine

Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction, Chinese Medicine

A Chinese Drug Made of Insects May Help Cardiac Patients

Small molecule metabolites: discovery of biomarkers and therapeutic targets

What You Should Know About Chinese Herbs

The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19 - ScienceDirect

The traditional Chinese medicine that could become 'key treatment' for heart attacks, as study finds it lowers inflammation without adverse effects

Comparison of the modified Singapore myocardial infarction registry risk score with GRACE 2.0 in predicting 1-year acute myocardial infarction outcomes